46 related articles for article (PubMed ID: 21134601)
1. Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.
Reithofer MR; Bytzek AK; Valiahdi SM; Kowol CR; Groessl M; Hartinger CG; Jakupec MA; Galanski MS; Keppler BK
J Inorg Biochem; 2011 Jan; 105(1):46-51. PubMed ID: 21134601
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterisation of Platinum(II) Diaminocyclohexane Complexes with Pyridine Derivatives as Anticancer Agents.
McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138979
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Antitumor Effects of Platinum-Based [Pt(
Stefàno E; Cossa LG; De Castro F; De Luca E; Vergaro V; My G; Rovito G; Migoni D; Muscella A; Marsigliante S; Benedetti M; Fanizzi FP
Bioinorg Chem Appl; 2023; 2023():5564624. PubMed ID: 37727647
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity.
McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175756
[TBL] [Abstract][Full Text] [Related]
5. The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH
Gabano E; Zanellato I; Pinton G; Moro L; Ravera M; Osella D
Bioinorg Chem Appl; 2022; 2022():3698391. PubMed ID: 36620349
[TBL] [Abstract][Full Text] [Related]
6. Heavy-Metal Trojan Horse: Enterobactin-Directed Delivery of Platinum(IV) Prodrugs to
Guo C; Nolan EM
J Am Chem Soc; 2022 Jul; 144(28):12756-12768. PubMed ID: 35803281
[TBL] [Abstract][Full Text] [Related]
7. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
Montagner D; Tolan D; Andriollo E; Gandin V; Marzano C
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486477
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.
Ling X; Tu J; Wang J; Shajii A; Kong N; Feng C; Zhang Y; Yu M; Xie T; Bharwani Z; Aljaeid BM; Shi B; Tao W; Farokhzad OC
ACS Nano; 2019 Jan; 13(1):357-370. PubMed ID: 30485068
[TBL] [Abstract][Full Text] [Related]
9. Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands.
Li X; Liu Y; Tian H
Bioinorg Chem Appl; 2018; 2018():8276139. PubMed ID: 30402082
[TBL] [Abstract][Full Text] [Related]
10. Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney.
Legin AA; Theiner S; Schintlmeister A; Reipert S; Heffeter P; Jakupec MA; Mayr J; Varbanov HP; Kowol CR; Galanski M; Berger W; Wagner M; Keppler BK
Chem Sci; 2016 May; 7(5):3052-3061. PubMed ID: 29997796
[TBL] [Abstract][Full Text] [Related]
11. A Family of Rhodium Complexes with Selective Toxicity toward Mismatch Repair-Deficient Cancers.
Boyle KM; Barton JK
J Am Chem Soc; 2018 Apr; 140(16):5612-5624. PubMed ID: 29620877
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells.
Olszewski U; Ulsperger E; Geissler K; Hamilton G
J Exp Pharmacol; 2011; 3():43-50. PubMed ID: 27186109
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.
Theiner S; Varbanov HP; Galanski MS; Egger AE; Berger W; Heffeter P; Keppler BK
J Biol Inorg Chem; 2015 Jan; 20(1):89-99. PubMed ID: 25413442
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.
Neumann W; Crews BC; Sárosi MB; Daniel CM; Ghebreselasie K; Scholz MS; Marnett LJ; Hey-Hawkins E
ChemMedChem; 2015 Jan; 10(1):183-92. PubMed ID: 25318459
[TBL] [Abstract][Full Text] [Related]
15. A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
Varbanov HP; Göschl S; Heffeter P; Theiner S; Roller A; Jensen F; Jakupec MA; Berger W; Galanski MS; Keppler BK
J Med Chem; 2014 Aug; 57(15):6751-64. PubMed ID: 25032896
[TBL] [Abstract][Full Text] [Related]
16. Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.
Zheng YR; Suntharalingam K; Johnstone TC; Yoo H; Lin W; Brooks JG; Lippard SJ
J Am Chem Soc; 2014 Jun; 136(24):8790-8. PubMed ID: 24902769
[TBL] [Abstract][Full Text] [Related]
17. Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.
Neumann W; Crews BC; Marnett LJ; Hey-Hawkins E
ChemMedChem; 2014 Jun; 9(6):1150-3. PubMed ID: 24801194
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.
Wilson JJ; Lippard SJ
Polyhedron; 2013 Jul; 58():71-78. PubMed ID: 24489429
[TBL] [Abstract][Full Text] [Related]
19. Synthetic methods for the preparation of platinum anticancer complexes.
Wilson JJ; Lippard SJ
Chem Rev; 2014 Apr; 114(8):4470-95. PubMed ID: 24283498
[No Abstract] [Full Text] [Related]
20. Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands.
Peng Y; Zhang MM; Chen ZF; Hu K; Liu YC; Chen X; Liang H
Bioinorg Chem Appl; 2013; 2013():565032. PubMed ID: 23533373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
